DiaMedica Therapeutics
(NASDAQ:DMAC)
$2.70
0.05[1.89%]
At close: Mar 28
$2.70
0[0.00%]
After Hours: 7:15AM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

DiaMedica Therapeutics Stock (NASDAQ:DMAC), Quotes and News Summary

DiaMedica Therapeutics Stock (NASDAQ: DMAC) stock price, news, charts, stock research, profile.

Open$2.730
Close$2.770
Volume / Avg.20.761K / 42.611K
Day Range2.730 - 2.810
52 Wk Range1.460 - 4.750
Market Cap$102.487M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
0.62%
Days to Cover7.58

Recent News

20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DMAC

FAQ

Q

How do I buy DiaMedica Therapeutics (DMAC) stock?

A

You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are DiaMedica Therapeutics's (DMAC) competitors?

A

There are no as such competitors for DiaMedica Therapeutics.

Q

What is the target price for DiaMedica Therapeutics (DMAC) stock?

A

The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Craig-Hallum on Thursday, March 21, 2024. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 196.30% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for DiaMedica Therapeutics (DMAC)?

A

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $2.7 last updated March 28, 2024 at 7:15 AM EDT.

Q

Does DiaMedica Therapeutics (DMAC) pay a dividend?

A

There are no upcoming dividends for DiaMedica Therapeutics.

Q

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

A

DiaMedica Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is DiaMedica Therapeutics (DMAC) going to split?

A

There is no upcoming split for DiaMedica Therapeutics.

Q

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

A

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.